1. Therapeutic targeting potential of chromatin-associated proteins in MLL-rearranged acute leukemia

   • Xin Xu
   • Björn Schneider

   Review 16 November 2018 Pages: 117 - 130

   

2. MicroRNA-mediated redox regulation modulates therapy resistance in cancer cells: clinical perspectives

   • Safieh Ebrahimi
   • Seyed Isaac Hashemy

   Review 15 January 2019 Pages: 131 - 141

   

3. Interfering with bromodomain epigenome readers as therapeutic option in mucoepidermoid carcinoma

   • Renata L. Markman
   • Liana P. Webber
   • Rogerio M. Castilho

   Original Article 11 December 2018 Pages: 143 - 155

   

4. Nanoquinacrine sensitizes 5-FU-resistant cervical cancer stem-like cells by down-regulating Nectin-4 via ADAM-17 mediated NOTCH deregulation

   • Anmada Nayak
   • Sarita Das
   • Chanakya Nath Kundu

   Original Paper 03 January 2019 Pages: 157 - 171

   

5. Secretome profiling of heterotypic spheroids suggests a role of fibroblasts in HIF-1 pathway modulation and colorectal cancer photodynamic resistance

   • María Julia Lamberti
   • Mandy Rettel
   • Natalia Belén Rumie Vittar

   Original Paper 12 February 2019 Pages: 173 - 196

   

6. Concomitant dysregulation of the estrogen receptor and BRAF/MEK signaling pathways is common in colorectal cancer and predicts a worse prognosis

   • Dingxie Liu

   Original Paper 15 January 2019 Pages: 197 - 209

   

7. SNHG6 is upregulated in primary breast cancers and promotes cell cycle progression in breast cancer-derived cell lines

   • Amin Jafari-Oliayi
   • Malek Hossein Asadi

   Original Paper 02 March 2019 Pages: 211 - 221

   

8. Antitumor effect of XCT790, an ERRα inverse agonist, on ERα-negative endometrial cancer cells

   • Tetsuya Kokabu
   • Taisuke Mori
   • Jo Kitawaki

   Original Paper 31 January 2019 Pages: 223 - 235

   

9. Nuclear localization of PD-L1: artifact or reality?

   • Hara Polioudaki
   • Amanda Chantziou
   • Panayiotis A. Theodoropoulos

   Commentary 25 January 2019 Pages: 237 - 242